Companies

MUbio Products produces immunological, including high quality antibody reagents and bioassays for cell biology and
biomedical research. A number of their antibodies have potential for clinical use in cancer diagnosis and treatment. In
addition, MUbio has established an IPR portfolio related to target discovery, as well as target molecules and vaccine design
technologies. These are applied in their vaccine development programs for lung cancer and cytomegalovirus.

www.mubio.com